MAKING CANCER MORE TREATABLE Trademark

Trademark Overview

On Wednesday, August 2, 2000, a trademark application was filed for MAKING CANCER MORE TREATABLE with the United States Patent and Trademark Office. The USPTO has given the MAKING CANCER MORE TREATABLE trademark a serial number of 76101138. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 10, 2023. This trademark is owned by Cell Therapeutics, Inc.. The MAKING CANCER MORE TREATABLE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

pharmaceutical, medical and laboratory research services in the field of pharmaceuticals, cancer, genetic disorders and gene therapy; providing information in the field of pharmaceuticals, medicine, cancer, genetic disorders and gene therapy; providing an online magazine in the fields of pharmaceuticals, medicine, cancer, genetic disorders and gene therapy; and consultation related to the foregoing
making cancer more treatable

General Information

Serial Number76101138
Word MarkMAKING CANCER MORE TREATABLE
Filing DateWednesday, August 2, 2000
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 10, 2023
Registration Number2711785
Registration DateTuesday, April 29, 2003
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 5, 2001

Trademark Statements

Goods and Servicespharmaceutical, medical and laboratory research services in the field of pharmaceuticals, cancer, genetic disorders and gene therapy; providing information in the field of pharmaceuticals, medicine, cancer, genetic disorders and gene therapy; providing an online magazine in the fields of pharmaceuticals, medicine, cancer, genetic disorders and gene therapy; and consultation related to the foregoing

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 10, 2023
Primary Code042
First Use Anywhere DateWednesday, May 31, 2000
First Use In Commerce DateWednesday, May 31, 2000

Trademark Owner History

Party NameCTI BIOPHARMA CORP.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSEATTLE, WA 98121
Party NameCell Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98121
Party NameCell Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119
Party NameCell Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119

Trademark Events

Event DateEvent Description
Friday, November 10, 2023CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Friday, April 29, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, June 12, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Thursday, May 14, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 14, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 6, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 6, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 6, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, May 6, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 6, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 6, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 6, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 6, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 2, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, April 2, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, April 2, 2013REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, April 2, 2013REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, April 1, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, March 19, 2013TEAS SECTION 8 & 9 RECEIVED
Saturday, April 25, 2009REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, April 17, 2009ASSIGNED TO PARALEGAL
Wednesday, April 15, 2009TEAS SECTION 8 & 15 RECEIVED
Thursday, January 17, 2008CASE FILE IN TICRS
Tuesday, April 29, 2003REGISTERED-PRINCIPAL REGISTER
Monday, February 24, 2003ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, February 24, 2003ASSIGNED TO EXAMINER
Wednesday, February 12, 2003STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 28, 2002USE AMENDMENT FILED
Tuesday, September 24, 2002SOU EXTENSION 2 GRANTED
Wednesday, August 28, 2002SOU EXTENSION 2 FILED
Wednesday, August 28, 2002PAPER RECEIVED
Wednesday, March 13, 2002SOU EXTENSION 1 GRANTED
Friday, February 22, 2002SOU EXTENSION 1 FILED
Tuesday, August 28, 2001NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 5, 2001PUBLISHED FOR OPPOSITION
Wednesday, May 23, 2001NOTICE OF PUBLICATION
Tuesday, January 23, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 11, 2001EXAMINER'S AMENDMENT MAILED
Wednesday, December 20, 2000ASSIGNED TO EXAMINER

Related Keywords

treatable more cancer making genetic disorders therapy pharmaceuticals gene providing field medicine magazine